Alliance for Cell Therapy Now Commends Congress for Regenerative Medicine and Cell Therapy Provisions in FY 2021 Spending Bill: Additional Support for Clinical Trials for COVID Patients is Still Needed
Washington, DC (December 30, 2020) – Leaders of Alliance for Cell Therapy Now (ACT Now)—including representatives of academic and medical institutions, industry innovators, and patients—applaud Congress for its inclusion of important provisions in the final FY 2021...
Former NFL Players Show Interest in Regenerative Medicine and Cell Therapies
Mount Laurel, NJ (October 14, 2020) – The National Football League Alumni Association (NFLA) today released a report exploring the interest in and use of regenerative medicine and cell therapies (RMCTs) for conditions of interest to NFLA members. “We are thrilled...